in New York City has announced a gift of more than $50 million from Laura and Isaac Perlmutter and the to advance cancer research and treatment.
The gift, the first in a larger commitment to NYU Langone by the couple, will enable NYU Langone to focus its cancer research, patient care, and education around efforts to produce better outcomes for patients; pursue greater program coordination and synergies; retain nationally recognized physicians and scientists; and provide for the education of clinical and scientific leaders at . In recognition of the gift, the NYU Cancer Institute will be renamed the .
Laura Perlmutter has been on NYU Langone's board of trustees since 1985 and on its cancer advisory board since 2005, while Isaac Perlmutter, chairman of Marvel Entertainment, recently was named to the board. The couple has previously contributed more than $8 million in support of NYU Langone.
"Our scientists and clinical researchers have made important contributions to the knowledge about the genetic and biochemical mechanisms by which cancer arises and behaves," said Dafna Bar-Sagi, senior vice president and vice dean for science and chief scientific officer at NYU School of Medicine. "We are now at a moment in history when there are great opportunities to make bold advances in cancer research. Simultaneously, the research community as a whole faces extreme challenges, contending with plunging national research budget cuts. The generosity of the Perlmutters at this critical time will allow us to continue to focus on the prevention and treatment of cancer and realize the full potential of the extraordinary research that goes on at NYU Langone."